ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.
Hamps Bio Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice of the 19th Annual General Meeting.
Hamps Bio Ltd has issued a notice for its 19th Annual General Meeting to be held on September 09, 2026.
Hamps Bio Ltd approved its Board Report, the notice for its 19th AGM scheduled for September 9, 2026, and a proposal to shift its registered office.
Hamps Bio Ltd updated stock exchange contact details for its Key Managerial Personnel. This is a routine compliance filing under SEBI LODR Regulation 30(5).
Ms. Komal Jain has resigned as Company Secretary and Compliance Officer. She will be relieved from her services on June 30, 2026.
Hamps Bio Ltd appointed M/s Naviwala & Associates as Internal Auditor for FY 2026-27. The appointment is effective from May 29, 2026, ensuring regulatory audit compliance.
Hamps Bio Ltd reported revenue from operations of ₹4.5 Cr (+45.2% YoY) and a net loss of ₹0.5 Cr for H2 FY26.
Hamps Bio Ltd approved audited FY26 results, reporting a consolidated net loss of ₹0.74 Crore. The board also appointed M/s Naviwala & Associates as internal auditors.
Hamps Bio Ltd scheduled a board meeting for May 29, 2026. Directors will consider audited standalone and consolidated financial results for the year ended March 2026.